Concerns over the toxicity of some of these drugs (McKellar and Scott 1990; Lankas and Peter 1992) led the European Union to establish Maximum Residue Limits (MRLs) for their residues in tissues of food-producing species (collated in European Commission 2010). Drugs, other than those listed in this legislation, are not licensed for use in food-producing animals and therefore their residues ought not to be present in food. The occurrence and determination of benzimidazole and macrocyclic lactone residues in biological matrices have recently been reviewed by Danaher et al. (2006; . Food safety and the exposure of the consumer to chemical residues in food are of continuing concern and there is an ongoing need for new analytical techniques and information on the occurrence of potentially harmful residues of veterinary drugs in our food. ProSafeBeef (www.prosafebeef.eu) is a EU Sixth Framework Integrated Project involving 41 leading research and industrial organisations working in 18 different countries, aiming to advance beef safety and the diversification of the European beef sector. Under this project, a novel analytical method, based on state-of-the-art ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), was developed simultaneously to detect 38 anthelmintic drug residues in bovine tissues (Kinsella et al. 2010; Whelan et al. 2010 ). This technique was subsequently applied in a survey of retail beef across Europe to determine the prevalence of anthelmintic drug residues in meat available to the European consumer, and in a study of the stability of anthelmintic drugs in solution, tissue extracts and stored tissue to assist the analyst in accurate quantification of residues of these drugs in food. Results of both these studies will be published elsewhere. Studies of the attitudes of consumers towards the safety of the meat they consume were also a major pillar of ProSafeBeef research (Van Wezemael et al. 2010) . Should unacceptable residues of anthelmintic drugs find their way into our foods, legislators, analysts and consumers alike will wish to know if such residues are destroyed when that food is cooked.
Between 1995 and 2005, Rose and co-workers in the UK Central Science Laboratory demonstrated that residues of a range of veterinary drugs exhibit varying degrees of stability during cooking and, therefore, that cooking influences the level of risk posed by such residues (Rose et al. 1996) . This compound-dependent stability during cooking is supported by studies of nitrofuran residues by Cooper and Kennedy (2007) and malachite green residues by Mitrowska et al. (2007) . However, to date, the assessment of the stability of anthelmintic drug residues in foods has been piecemeal and limited to the effects of pasteurisation on the macrocyclic lactones, including ivermectin, in milk (Imperiale et al. 2009; Cerkvenik et al. 2001) , and the effects of various cooking procedures on ivermectin in porcine liver and bovine, porcine and salmon muscle (Rose et al. 1998; Slanina et al. 1989 ), levamisole in bovine and porcine muscle (Rose et al. 1995a; Hsu and Epstein 1993) and oxfendazole in bovine liver (Rose et al. 1997 ).
To complement the outcomes of the ProSafeBeef European retail beef survey and aid relevant authorities and the consumer in assessing their exposure to anthelmintic drug residues, the current study set out to determine the stability during cooking, by frying and roasting, of a wide range of anthelmintic residues in meat and liver of cattle treated with commercially available veterinary parasiticide preparations. 
Materials and methods

Materials and instrumentation
Reference standards and internal standards analysed in this study are listed in Table 1 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Tissues were minced in a domestic food processor before homogenisation in a SL2 laboratory homogeniser (Silverson Machines Ltd., Chesham, UK). QuEChERS dispersive clean-up tubes (1.5
g MgSO 4 and 0.5 g C 18 in 50 mL centrifuge tubes) were obtained from UCT (Bristol, PA, USA).
QuEChERS extraction salts, anhydrous MgSO 4 (4 g) and NaCl (1 g), were obtained from SigmaAldrich and pre-weighed in-house.
[INSERT TABLE 1 ABOUT HERE]
Production of incurred bovine tissues
Seven pasture-fed beef cattle (male, 16-17 months of age, approximately 450 kg body weight) were treated with commercially available parasiticide preparations (comprising 11 active ingredients corresponding to 21 marker residues) at the manufacturers' recommended doses and routes (subcutaneous injection or oral drench) split half-and-half over two consecutive days (Table 2 ).
Administration was staggered over two days to encourage the formation of both parent and metabolite drug residues in the tissues. Short withdrawal periods of one or two days were observed after the second dose before cattle were slaughtered and Longissimus dorsi muscle (sirloin/filet steak) and liver were sampled. Tissues were stored at -20°C prior to analysis. 
Cooking of incurred beef and liver
One portion of L. dorsi muscle and one portion of liver were selected from each medicated cow.
After thawing to room temperature, adjoining pieces of muscle were sliced for frying (mean 185 g) and roasting (mean 300 g). A third adjoining slice was retained for analysis without cooking.
Single slices of liver (mean 170 g) were taken for frying and adjoining uncooked slices retained for analysis without cooking. Excess juices and blood were removed from each sample using absorbent tissue before weighing immediately prior to cooking (or before mincing of uncooked samples). Cooked samples were re-weighed after cooling to room temperature and removal of excess juices. Cooked and raw samples were then individually minced in a domestic food processor and re-frozen at -20°C prior to analysis by LC-MS/MS. Cooking conditions were as follows.
Roasting. Muscle was roasted for 40 min at 190°C on the middle shelf of a pre-heated fan-assisted domestic oven, while wrapped in aluminium foil in an uncovered tray. All juices expressed during roasting were collected and weighed.
Frying. Muscle was fried for 4-6 min each side (depending on sample size, to give medium cooked meat) on a high heat setting on a domestic ceramic hob, in a minimal volume of sunflower oil (one teaspoon) to prevent burning. Small volumes of expressed juices were collected following frying of the majority of muscle samples. Liver was fried in approximately 10 mL sunflower oil, searing for 2 min each side on a high heat setting, then frying on medium heat for a further 10-15 min, depending on sample size, to give well done cooked liver in the centre of the portion. Significant amounts of juices were not expressed during frying of liver.
The maximum internal temperature of each sample was measured on completion of cooking by inserting a digital penetration probe thermometer into the centre of the sample. 
LC-MS/MS analysis
Each sample, raw and cooked, was analysed in triplicate as described below. Juices were analysed in duplicate. Different sample types were stored under identical conditions at all times and analysed in the same analytical batch to avoid time-dependent (stability) differences in residue concentrations. This analytical method is based on the QuEChERS-UPLC-MS/MS protocol developed by Kinsella et al. (2009; 2010) under the ProSafeBeef project.
Briefly, samples (10 g) were extracted by homogenisation in acetonitrile (12 mL). Phase separation was achieved by shaking homogenised samples with anhydrous MgSO 4 (4 g) and NaCl (1 g).
Following centrifugation, the supernatant was cleaned-up using dispersive SPE by vortex mixing with anhydrous MgSO 4 (1.5 g) and C 18 sorbent (0.5 g). Following centrifugation, a portion of the extract (1-3 mL) was mixed with dimethylsulphoxide (DMSO, 0.5-1 mL) and the acetonitrile evaporated under nitrogen at 50°C. The volumes of extract and DMSO employed were varied for a given analytical batch to keep the MS/MS signal within a linear range. Furthermore, highly concentrated samples were diluted with L. dorsi muscle or liver from untreated cattle, up to a total of 10 g, prior to homogenisation. Extracted matrix calibration standard curves were prepared by fortifying 10 g of L. dorsi muscle or liver from untreated cattle with standard mixtures prior to homogenisation and extraction. Final extracts in DMSO were injected (4 µL) onto the AcquityPremier XE UPLC-MS/MS system described above. Ionisation polarities and internal standards applied are listed in Table 1 . Calibration standards (n=5 to 7 depending on range of linearity) were injected in duplicate with acceptable regression coefficients (r 2 ) above 0.98 for analytes employing isotopic internal standards and 0.95 for those employing non-isotopic internal standards (Table 1) .
Analyte concentrations in samples were calculated by comparing the ratio of the response of the analyte's base peak to the internal standard response with the same ratio in calibration curve standards, followed by a correction for any sample dilution applied prior to extraction. For those samples from which juices were expressed, mean residues detected in cooked tissue and juices were combined in absolute terms (µg residue in total cooked sample + µg residue in total cooked juices) to permit comparison with µg of residue in total uncooked sample (Tables 4-5 ).
Replicate data (n=3) from tissues and juices cannot be paired to give replicate concentration data for combined cooked samples, therefore a t-test cannot be applied. A t-test could be applied only to triplicate analyses of the tissue concentrations without reference to juice concentrations.
[INSERT TABLES 3, 4 AND 5 ABOUT HERE] Maximum internal sample temperatures during cooking ranged from 55 to 96°C (Tables 3-5 ). In keeping with the differing sample sizes and cooking times, higher internal temperatures were achieved during roasting of muscle (mean 88°C) than frying (mean 65°C). Liver, fried thoroughly for up to 19 min, reached the highest temperatures (mean 91°C).
Major residue instability was evident only for nitroxynil which dropped by 96% in roast muscle and by 78% in fried muscle (Tables 4 and 5 ). Nitroxynil was not detected in uncooked liver. This disparity between nitroxynil concentrations in uncooked bovine muscle (531 µg kg -1 ) and liver (<10 µg kg -1 ) is in keeping with a previous report indicating that up to 98% of nitroxynil was metabolised in the liver of treated cattle (EMEA 1999). Our observed loss of nitroxynil in muscle is in agreement with the limited data of Ekström and Slanina (1982) who saw the complete destruction of nitroxynil in beef boiled for 2 h and a loss of up to 55% when fried.
Smaller, but significant, losses of levamisole (42% in fried liver, 11% in fried muscle), rafoxanide (17% in fried muscle, 18% in roast muscle) and triclabendazole (23% in fried liver, 47% in roast muscle) were also seen in the current study.
A small loss of levamisole from fried bovine muscle (11%) was observed. Rose et al. (1995a) saw no loss of levamisole during frying of incurred porcine muscle or in boiling water at 100°C.
Roasting bovine muscle in the current study led to a 17% loss of levamisole in the meat but this was wholly accounted for by the residue detected in the expressed juices (Table 5) . Rose et al. (1995a) also demonstrated a loss of levamisole during roasting of porcine muscle but expressed juices were not analysed in that instance. Hsu and Epstein (1993) suggested that levamisole was stable under ordinary cooking conditions, although a 26% decrease was evident during broiling of porcine muscle. The present study, however, clearly demonstrated a 42% loss of levamisole during frying of incurred bovine liver (not studied by Rose). Given that levamisole migrated into expressed juices during roasting of muscle to a greater degree than any other residue in this study (17% of total levamisole residues post-cooking were detected in the juices; Table 5 ), it is conceivable that this 42% loss may be accounted for, at least in part, by juices expressed during frying which then evaporated in the pan and were thus unavailable for analysis. Levamisole residues remaining in the pan following evaporation of expressed juices may still be ingested if the consumer chooses to prepare sauces or gravy in the same pan.
Rafoxanide (Tables 3-5 ) was seen to decrease by 17-18% in cooked muscle and by 12% in fried liver (although this was not statistically significant). Caldow et al. (2009) demonstrated that rafoxanide was generally stable during storage, although degradation in fortified tissue and low concentration solvent solution was evident after one week storage at room temperature in daylight.
The significance of a minor reduction (less than one fifth) in residues of a drug to which relatively low EU Maximum Residue Limits have been assigned (30 µg kg -1 bovine muscle and 10 µg kg -1 bovine liver; Table 2 ) is debatable. Consumers want their meat to be residue-free on the supermarket shelf, and on their plate, and will view such partial degradation of residues during cooking as no safeguard to their health or the perceived quality of their food. Furthermore, it cannot be discounted that residues of any compound lost during cooking are in fact being converted to unidentified products with equal or greater toxicity.
Triclabendazole was the only benzimidazole compound which exhibited instability during cooking when expressed as the sum of its metabolites as defined by Commission Regulation 37/2010 (European Commission 2010). Total triclabendazole fell by 23% in fried liver and by 47% in roast muscle. This two-fold difference in stability (cooking temperatures were comparable) may be due in part to the different starting metabolite concentrations in the uncooked tissues. TCB-SO 2 is the predominant metabolite in muscle, followed by TCB, while the reverse is the case in liver (Tables 3   and 4 ). However, in both tissues TCB-SO 2 exhibited higher percentage losses than TCB during cooking, leading to a substantially greater reduction in total triclabendazole residues in muscle than in liver. Total triclabendazole did not fall significantly when muscle was fried -the treatment Minor statistically significant reductions (6%) in total albendazole and total mebendazole residues were evident in roast muscle, but these can be considered negligible in the context of food safety.
Analysis of the metabolites of albendazole suggests a shift towards higher ABZ-NH 2 -SO 2 concentrations when liver and muscle are fried, but this was not evident when muscle was roasted (Tables 3-5) . Analysis of the metabolites of mebendazole suggested no shift in their relative concentrations during cooking with the exception of NH 2 -MBZ which doubled its concentration in liver during frying, leading to a considerable 86% increase in total mebendazole residues. This change was not replicated in cooked muscle in which the starting concentration of mebendazole residues was 10 fold lower than in liver. The source of this elevated NH 2 -MBZ in fried liver was not transformation of MBZ or OH-MBZ, and must therefore be attributed to other unidentified hepatic metabolites of mebendazole. Rose et al. (1997) postulated the formation of an amine of oxfendazole (FBZ-SO) when cooking incurred bovine liver and concluded that, while cooking did not destroy the residues, it may affect the equilibrium between FBZ-SO, FBZ-SO 2 , FBZ and other unidentified fenbendazole metabolites in incurred tissue. The current study supports this assertion. FBZ-SO is a very minor metabolite in muscle and no significant change in total fenbendazole residues or shift in the relative concentrations of its metabolites was evident following cooking. Similarly, no significant drop in total fenbendazole residues was seen following frying of incurred liver although the concentration of FBZ-SO 2 did fall by 80%. Slanina et al. (1989) observed ivermectin losses of up to 50% when bovine muscle was minced before boiling or frying. In the former study, the majority of the missing residue was detected in the cooking fluids which the latter study did not analyse.
In addition to ivermectin, the flukicides oxyclozanide, closantel and clorsulon exhibited no instability under cooking in the present study. However, statistically significant increases (27-29%)
were apparent for oxyclozanide and clorsulon after frying of muscle (Table 4 ). As postulated above for NH 2 -MBZ, these increases may arise from transformation of other unidentified metabolites during cooking, although it is difficult to explain why they were not replicated in roast muscle or fried liver.
Migration of drug residues into expressed juices during cooking is one aspect of studies such as this which is difficult to control and to assess accurately. The availability of expressed juices is sample and operator-dependent, being affected by many factors including the fat and water contents of the tissue, cooking temperature, the physical treatment of the tissue (slicing, squeezing) and resting time post-cooking. Furthermore, the fate of any residues which do migrate into cooking juice is dependent upon consumer choice -the choice to discard juices or use them in sauces or gravy or to baste the meat. Culinary practices do not always fit neatly with analytical laboratory practices.
Nevertheless, the evidence of the current study suggests that migration of anthelmintic drug residues into juices during roasting or shallow frying of beef or bovine liver is not a major consideration. With the exception of levamisole (17% from roast muscle), residues in expressed juices constituted only 8% or less of the total residues remaining after cooking (Tables 4 and 5 ).
The extent of drug residue migration into cooking juices is known to be dependent upon the In summary, with the exception of nitroxynil, residues of anthelmintic drugs in beef and bovine liver were generally resistant to degradation during roasting and frying. Apparent increases in residue concentrations during cooking may be due to conversion of unidentified metabolites into the specified marker residues. Consequently, conventional domestic cooking cannot be considered a safeguard against ingestion of residues of commonly used anthelmintic veterinary drugs in beef. cooking and supports the approach of minimising and controlling the use of veterinary medicines at source to safeguard both the health of the consumer and the profitability of food producers. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Determination of anthelmintic drug residues in milk using ultra high performance liquid chromatography-tandem mass spectrometry with rapid polarity switching. J Chromatogr A 1217: 4612-4622. O n l y O n l y Table 3 . Effect of frying on concentration of anthelmintic drug residues in bovine liver. Concentration data are mean ± standard error (n=3 O n l y 
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